You probably know this already if you know enough to ask that question, but..
..be careful with lentiviral vectors, or any other vector capable of transforming mammalian cell lines in-vitro. Because they can still efficiently transduce those genes into cells in-vivo, for example when you breathe the aerosol produced by most micro-pipette tips while handling viable lentivirus particles.
Having studied viral/nonviral gene therapy techniques for years, I can comfortably tell you that most lentiviral vectors are NOT designed for safe use, and those that are alleged to be "safe" usually aren't. Lentiviruses, and the vectors that derive from them, tend to inject their DNA semirandomly into genomic regions, usually near to gene-rich regions, and if they carry a strong promoter (usually the case, especially for whiz-bang GFP projects), they can and do happily activate oncogenes downstream. At the very least, they can cause nearby heterochromatin to unwind, leading to similar activation of unwanted genes.
In all likelihood, such mutant cells will get killed by the immune system in short order (MHC presentation of GFP tends to raise T-cell eyebrows); I imagine this is why cases of experimenters with self-inflicted cancer are not very common. But it should be considered when working with lentivirii, adenovirii or even adeno-associated virii: they can transfect YOU as well as the cell line. At least with AAV, genomic integration is usually pretty predictable..
www.indiebiotech.com
twitter.com/onetruecathal
joindiaspora.com/u/cathalgarvey
PGP Public Key: http://bit.ly/CathalGKey